mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.006 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.006 |
mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.006 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.33 |
0.006 |
mRNA |
BHG712 |
GDSC1000 |
pan-cancer |
AAC |
-0.086 |
0.007 |
mRNA |
phloretin |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.007 |
mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
0.094 |
0.007 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.007 |
mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.007 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.007 |